| Role |
Name |
Disclosure |
Details |
| Author | Elizabeth Kline Satter, MD, MPH, Staff Dermatologist and Head of Dermatopathology for Residency Program, Department of Dermatology, Naval Medical Center, San Diego | Nothing to disclose | Details | | Medical Editor | Daniel J Hogan, MD, Director of Bay Pines Dermatology Residency Program, Bay Pines Veterans Affairs Healthcare System; Investigator, Hill Top Research, Florida Research Center | Nothing to disclose | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Paul Krusinski, MD, Director of Dermatology, Professor, Department of Internal Medicine, Fletcher Allen Health Care, University of Vermont | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Paul Krusinski, Managing Editor |
The contributor discloses no conflict of interest. |
|